Ruth McBride

Ruth McBride, BS, is chief technology officer with Axio Research Corporation, a division of Solutia Pharmaceutical Services Division, 2601 4th Avenue, Suite 200, Seattle, WA, 98121, (206) 577-0217, fax (206) 547-4671, email: davidk@axioresearch.com.

Articles by Ruth McBride

Evaluating the Effects of Therapy Masking

ByRuth McBride,Barbara A Ricker,Alexander R Arslan,Katherine M Seymour,April Slee,Jeffrey L Probstfield, MD

October 1st 2015

Using a specific trial, the importance of assessing the success of therapy masking is examined.

Evaluating the Effects of Therapy Masking

ByRuth McBride,Barbara A Ricker,Alexander R Arslan,Katherine M Seymour,April Slee,Jeffrey L Probstfield, MD

March 13th 2015

An important criterion for a well-conducted clinical trial is minimization of bias in endpoint assessment.

Latest Updated Articles

Evaluating the Effects of Therapy Masking
Published: March 13th 2015 | Updated:
Evaluating the Effects of Therapy Masking
Published: October 1st 2015 | Updated: